Harvard Bioscience, Inc. (HBIO)
After hours:
| Previous Close | 3.3500 |
| Open | 3.4200 |
| Bid | 3.2800 x 200 |
| Ask | 3.3100 x 300 |
| Day's Range | 3.2000 - 3.4200 |
| 52 Week Range | 2.7000 - 5.5600 |
| Volume | |
| Avg. Volume | 157,261 |
| Market Cap | 143.318M |
| Beta (5Y Monthly) | 1.31 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.2000 |
| Earnings Date | Aug 06, 2024 - Aug 12, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 6.92 |
Simply Wall St.Harvard Bioscience Insider Ups Holding During Year
Insiders were net buyers of Harvard Bioscience, Inc.'s ( NASDAQ:HBIO ) stock during the past year. That is, insiders...
GlobeNewswireHarvard Bioscience, Inc. to Present and Host One-on-One Meetings at the 14th Annual East Coast IDEAS Conference on June 12, 2024
HOLLISTON, Mass., June 06, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be presenting to investors at the 14th Annual East Coast IDEAS Conference at the Jay Conference Center – Bryant Park in New York City on June 12, 2024. The Company’s presentation is scheduled for 2:45-3:20 PM ET on June 12th. The Company will also host one-on-one investor meetings through
- GlobeNewswire
Harvard Bioscience, Inc. to Present at the Jefferies Global Healthcare Conference on June 5, 2024
HOLLISTON, Mass., May 23, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be presenting to investors at the Jefferies Global Healthcare Conference at the Marriott Marquis in New York City on June 5, 2024. The Company’s presentation will be 2:00-2:25 PM ET on June 5th. The presentation will be webcast live and can be accessed through the investor relations sectio
